Nuclear localization of the pre-mRNA associating protein THOC7 depends upon its direct interaction with Fms tyrosine kinase interacting protein (FMIP)

FEBS Letters

Volumn 583, Issue 1, 2009, Pages 13-18

  El Bounkari, Omar ^a   Guria, Anuja ^a   Klebba Faerber, Sabine ^a   Claußen, Maike ^b   Pieler, Tomas ^b   Griffiths, John R ^c   Whetton, Anthony D ^c   Koch, Alexandra ^a   Tamura, Teruko ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

FMIP THOC5 fSAP79; mRNA processing complex; Nucleocytoplasmic shuttling protein; THOC7 fSAP24

Indexed keywords

BINDING PROTEIN; CYTOPLASM PROTEIN; FMS TYROSINE KINASE INTERACTING PROTEIN; PROTEIN THOC7; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CELL NUCLEUS; CHEMICAL INTERACTION; COMPLEX FORMATION; CYTOPLASM; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

AMINO ACID MOTIFS; ANIMALS; CELL NUCLEUS; HUMANS; MICE; MUTATION; NUCLEAR LOCALIZATION SIGNALS; NUCLEAR PROTEINS; PROTEIN INTERACTION MAPPING; RNA PRECURSORS; RNA-BINDING PROTEINS; XENOPUS; XENOPUS PROTEINS;

EID: 57749189801     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2008.11.024     Document Type: Article

References (20)

1. Tascou S., Kang T.W., Trappe R., Engel W., and Burfeind P. Identification and characterization of NIF3L1 BP1, a novel cytoplasmic interaction partner of the NIF3L1 protein. Biochem. Biophys. Res. Commun. 309 (2003) 440-448
2. Tamura T., Mancini A., Joos H., Koch A., Hakim C., Dumanski J., Weidner K.M., and Niemann H. FMIP, a novel Fms-interacting protein, affects granulocyte/macrophage differentiation. Oncogene 18 (1999) 6488-6495
3. Pierce A., Carney L., Hamza H.G., Griffiths J.R., Zhang L., Whetton B.A., Sanchez M.B.G., Tamura T., Sternberg D., and Whetton A.D. Thoc5 spliceosome protein: a target for leukemogenic tyrosine kinases that affects inositol lipid turnover. Br. J. Hematol. 141 (2008) 641-650
4. Gridley S., Lane W.S., Garner C.W., and Lienhard G.V. Novel insulin-elicited phosphoproteins in adipocytes. Cell Signal. 17 (2005) 59-66
5. Mancini A., Koch A., Whetton A.D., and Tamura T. The M-CSF receptor substrate and interacting protein FMIP is governed in its subcellular localization by protein kinase C-mediated phosphorylation, and thereby potentiates M-CSF-mediated differentiation. Oncogene 23 (2004) 6581-6589
6. Rehwinkel J., Herold A., Gari K., Kocher T., Rode M., Ciccarelli F.L., Wilms M., and Izaurralde E. Genome-wide analysis of mRNAs regulated by the THO complex in Drosophila melanogaster. Nat. Struct. Mol. Biol. 6 (2004) 558-566
7. Reed R., and Cheng H. TREX, SR proteins and export of mRNA. Curr. Opin. Cell Biol. 17 (2005) 269-273
8. Chavez S., and Aguilera A. The yeast HPR1 gene has a functional role in transcriptional role in transcriptional elongation that uncovers a novel source of genome instability. Gene Dev. 11 (1997) 3459-3470
9. Chavez S., Beilharz T., and Rondon A. A protein complex containing Tho2, Hpr1, Mft1 and a novel protein, Thp2, connects transcription elongation with mitotic recombination in Saccharomyces cerevisiae. EMBO J. 19 (2000) 5824-5834
10. Piruat J.I., and Aguilera A. A novel yeast gene, THO2, is involved in RNA pol II transcription and provides new evidence for transcriptional elongation-associated recombination. EMBO J. 17 (1998) 4859-4872
11. Jimero S., Rondon A.G., Luna R., and Aguiliera A. The yeast THO complex and mRNA export factors link RNA metabolism with transcription and genome instability. EMBO J. 21 (2002) 3526-3535
12. Strasser K., Masuda S., Mason P., Pfannstiel J., Oppizzi M., Rodriguez-Navarro S., Rondon A.G., Aguilera A., Struhl K., Reed R., and Hurt E. TREX is a conserved complex coupling transcription with messenger RNA export. Nature 417 (2002) 304-308
13. Masuda S., Das R., Cheng H., Hurt E., Dorman N., and Reed R. Recruitment of the human TREX complex to mRNA during splicing. Genes Dev. 19 (2005) 1512-1517
14. Cheng H., Dufu K., Lee C.-S., Hsu J.L., Dias A., and Reed R. Human mRNA export machinery recruited to the 5′ end of mRNA. Cell 127 (2006) 1389-1400
15. Merz C., Urlaub H., Will C.L., and Lührmann R. Protein composition of human mRNPs spliced in vitro and differential requirements for mRNP protein recruitment. RNA 13 (2007) 116-128
16. Mancini A., El Bounkari O., Norrenbrock A.-F., Scherr M., Schaefer D., Eder M., Banham A.H., Pulford K., Lyne L., Whetton A.D., and Tamura T. FMIP controls the adipocyte lineage commitment of C2C12 cells by downmodulation of C/EBP alpha. Oncogene 26 (2007) 1020-1027
17. Koch A., Scherr M., Breyer B., Mancini A., Kardinal C., Battmer K., Eder M., and Tamura T. Inhibition of Abl tyrosine kinase enhances nerve growth factor (NGF) mediated signaling in Bcr-Abl transformed cells via the alteration of signaling complex and the receptor turnover. Oncogene 27 (2008) 4678-4689
18. Mancini A., Koch A., Wilms R., and Tamura T. C-Cbl associates directly with the C-terminal tail of the receptor for macrophage colony stimulating factor, c-Fms, and down-modulates this receptor but not the viral oncogene v-Fms. J. Biol. Chem. 277 (2002) 14635-14640
19. Gasparri F., Sola F., Lacatelli G., and Muzio M. The death domain protein p84N5, but not the short isoform p84N5s, is cell cycle-regulated and shuttles between the nucleus and the cytoplasm. FEBS Lett. 574 (2004) 13-19
20. Li Y., Lin A.W., Zhang X., Wang Y., Wang X., and Goodrich D.W. Cancer cells and normal cells differ in their requirements for Thoc1. Cancer Res. 67 (2007) 6657-6664